Striatum (ST). Accordingly, current PD therapies focus on maintaining dopamine levels of brain at normal range. However, this approach is fairly useful to control and manage Parkinsonâ??s disease ... implies some…
randomized, controlled and single-blinded study lasted 3 years, on 20 subjects affected by a moderate form of idiopathic Parkinson’s disease (PD), in stable treatment with L-dopa ... patients showed greater improvements…
randomized, controlled and single-blinded study lasted 3 years, on 20 subjects affected by a moderate form of idiopathic Parkinsonâ??s disease (PD), in stable treatment with L-dopa ... patients showed greater…
gastric, and colonic surgical procedures. The lack of any advantage of systematic NGTD following PD has been previously suggested in a few retrospective studies although without the stronger level ... from retrospective…
structural and morphological information.[2] As a major result, it will be shown that controlling the surface molecular structure of monoliths enables (i) designing miniaturized separation columns allowing the…
quality of life (QOL), withdrawal of PD, and high mortality rate in dialysis patients; therefore, it is clinically important to maintain RRF. Control of blood pressure, inhibition of the renin ... angiotensin system…
quality of life (QOL), withdrawal of PD, and high mortality rate in dialysis patients; therefore, it is clinically important to maintain RRF. Control of blood pressure, inhibition of the renin ... angiotensin system…
performed a meta-analysis of the risk of selected musculoskeletal toxicities associated with the PD-1 inhibitor Nivolumab versus other drugs. Methods: Several databases were searched. We assess the relevant…
decades, repetitive Transcranial Magnetic Stimulation (rTMS) has been increasingly employed in Parkinson’s disease (PD) to enhance and restore motor function. Different cortical regions have been investigated as…
possibly connected to the metabolism of Aβ and α-synuclein protein in diabetes, AD, PD and Huntingtonâ??s disease. Interests in proteins and their interactions with membrane lipids in neurodegenerative ... these genes…
million Americans. It is estimated there will be an increase from 4.1 million PD patients in 2005 to 8.7 million by the year 2030, making it particularly important to find ... dyskinesis have been encountered by some of…
that many individuals with Pakinson's disease (PD) have a vitamin B3 deficiency. Levels were 3.4 standard error lower than age-matched controls. The deficiency may be related to carbidopa ... trial to determine the…
that many individuals with Parkinson’s Disease (PD) have a vitamin B3 deficiency. Levels were 3.4 standard error lower than age-matched controls. The deficiency may be related to carbidopa ... trial to determine the…
like inclusion formation. In humans, both PD patients and pre-symptomatic subjects reached this pathogenic threshold of intracellular melanin, in contrast to control healthy brains. At the molecular level, decreases…
children with PD. Children with oligoanuria in both groups conducted diagnostic tests of blood levels of urea and creatinine determination of creatinine clearance and urea clearance, echocardiography-control study
system consists of three main elements: Insulin delivery, continuous glucose sensing and a controller or algorithm, that is similar to the beta cell, regulates the proper amount of insulin delivery ... proper time…
central role in the pathogenesis of PD, thus it represents the focus of treatment efforts. Other neurotransmitters also play a major role in controlling symptoms that related to cognitive behaviors ... strategy in…
known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies for cancer immunotherapy. The next generation active immune checkpoint control immunotherapy which based
known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies for cancer immunotherapy. The next generation active immune checkpoint control immunotherapy which based
frontline treatment choices (PD). Treatment with dopaminergic agents, especially agonist therapies (ATs), can, however, cause pernicious behavioural syndromes in some patients, which are classified as Impulse Control…
individuals as controls. An attempt was made to study the role of blood reduced glutathione (GSH), Glutathione-S- transferase (GST) and γ-Glutamyl transpeptidase (GGT) in PD. The results showed
central role in the pathogenesis of PD, thus it represents the focus of treatment efforts. Other neurotransmitters also play a major role in controlling symptoms that related to cognitive behaviors ... strategy in…
diagnosed with NS-NSCLC exhibiting PD-L1 overexpression. Among them, 50 individuals were allocated to the observation group and another 50 to the control group as per the treatment strategy ... year survival rate of…
oxDJ-1 was 124.07 ± 13.7 ng oxDJ-1/mg protein in 43 un-treated PD patients group; 88.0 ± 29.8 ng oxDJ-1/mg protein in 9 PSP patients group ... level in 17 control group was 56.0 ± 6.2 ng oxDJ-1/mg protein, showing…
Time Task (SRTT) was used to assess procedural memory in 22 patients diagnosed with PD. This included seven blocks of ten stimuli with 30 seconds break between each block. After ... stimuli, followed by the previously…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.